Nubiyota |
- |
Microbiome therapeutics platform |
Microbiome Insights |
BC - Vancouver |
Microbiome Analysis and Research |
A-Mansia Biotech |
Belgium - Mont-Saint-Guibert |
Microbiome Therapies |
Actym Therapeutics |
CA - Berkeley |
Microbial-based immunotherapy platform |
SciBac |
CA - Burlingame |
Live Microbial Therapeutics |
Evolve BioSystems |
CA - Davis |
Probiotic Bacteria |
Metagenomi |
CA - Emeryville |
Gene-Edited Microbial Treatments |
Pareto Bio |
CA - La Jolla |
Microbial therapies to prevent and treat human disease and allergies |
Osel |
CA - Mountain View |
Live Organisms as Treatments |
Siolta Therapeutics |
CA - San Carlos |
Gut Microbiome Modification |
Bloom Science |
CA - San Diego |
Microbiota-Based Drug Discovery |
Naked Biome |
CA - San Francisco |
Microbiome-discovery |
Federation Bio |
CA - South SF |
Design, discover, and develop robust communities of microbes |
Novome Biotechnologies |
CA - South SF |
Gut Microbiome-Derived Cell Therapies for Chronic Diseases |
Second Genome |
CA - South SF |
Microbiome modulators |
Forte Biosciences |
CA - Torrance |
Atopic Dermatitis Treatment |
BioPlx |
CO - Boulder |
Non-antibiotic methods for the control of infectious disease |
Azitra |
CT - Farmington |
Microbiome Skin Treatments |
Artizan Biosciences |
CT - New Haven |
Microbiota-targeted therapies |
SNIPR Biome |
Denmark - Copenhagen |
CRISPR for microbiome management |
Ysopia Bioscience |
France - Bordeaux |
Gut-microbiome-based therapies |
Exeliom Biosciences |
France - Dijon |
Gut microbiome modifiers |
Biocodex |
France - Gentilly |
Microbiota Treatments |
Vaiomer |
France - LABEGE |
Microbial Characterization |
MaaT Pharma |
France - Lyon |
Microbiome Correction |
DA VOLTERRA |
France - Paris |
Microbiota Protection |
Eligo Bioscience |
France - Paris |
Protein-based nanodelivery vectors |
Enterome |
France - Paris |
Microbiome-related diseases, diagnostics |
Biome360 |
GA - Alpharetta |
Consumer Gut Microbiome Analysis |
BiomeSense |
IL - Chicago |
Biosensor & cloud-based software platform for gut microbiome analysis |
Scioto Biosciences |
IN - Indianapolis |
Delivery of microbiome therapeutics |
BiomX |
Israel - Ness Ziona |
Microbiome-based Therapeutics |
Genome & Company |
Korea - Gyeonggido |
Microbiome, Antibody Therapies |
GI Innovation |
Korea - Seoul |
Microbiome combination drug development |
Kobiolabs |
Korea - Seoul |
Microbiome Therapeutics |
BioLeaders |
Korea - Yongin |
Mucosal Immunity Medicine |
DeepBiome Therapeutics |
MA - Allston |
Microbiome Drug Discovery |
DermBiont |
MA - Boston |
Topical Bacterial Products |
GRO Biosciences |
MA - Boston |
Genetically altered bacteria for drug improvement |
AOBiome |
MA - Cambridge |
Bacterial skin therapy |
Enterome |
MA - Cambridge |
Microbiome-related diseases, diagnostics |
Holobiome |
MA - Cambridge |
Microbiome Therapeutics Targeting Nervous System |
LUCA Biologics |
MA - Cambridge |
Treatment Targeting Vaginal Microbiome |
Seres Therapeutics |
MA - Cambridge |
Microbial drugs to counteract antibiotic side effects |
Solarea Bio |
MA - Cambridge |
Microbiome Treatments |
Vedanta Biosciences |
MA - Cambridge |
Therapies that modulate pathways of interaction between the human microbiome and the host immune system |
Artugen Therapeutics |
MA - Concord |
Live Bacterial Treatments |
Kaleido Biosciences |
MA - Lexington |
Compounds Designed for Microbiome Targets |
Finch Therapeutics |
MA - Somerville |
Microbiological Therapy |
Axial Therapeutics |
MA - Waltham |
Neurology-Microbiome research |
Diversigen |
MN - New Brighton |
Microbiome Analysis |
Rebiotix |
MN - Roseville |
Microbiota Restoration Therapy |
Symberix |
NC - Durham |
Small molecules that act upon human microbiome |
Locus Biosciences |
NC - Morrisville |
CRISP-engineered Bacteriophage Therapeutics |
Caelus Health |
Netherlands - Amsterdam |
Microbiome therapeutics for type 2 diabetes in people w/ metabolic syndrome |
Bio-Me |
Norway - Oslo |
Microbiome Profiling |
MedBiome |
ON - Ottawa |
Screening compounds for gut microbiome impact |
SFA Therapeutics |
PA - Jenkintown |
Microbiome-derived metabolites as drugs |
Microviable Therapeutics |
Spain - Gijon |
Intestinal Microbiota Isolation Kit |
Infant Bacterial Therapeutics |
Sweden - Stockholm |
Premature Infant Treatments |
MetaboGen |
Sweden - Stockholm |
Therapeutics and Probiotics |
Aurealis Therapeutics |
Switzerland - Basel |
Transdermal |
T3 Pharmaceuticals |
Switzerland - Basel |
Bacterial Cancer Therapy |
Redbiotec |
Switzerland - Schlieren |
Various Biologic Modalities |
PharmaBiome |
Switzerland - Zurich |
R&D treatment of myelin-related/neurodegenerative disorders by targeting glia |
OM Pharma |
Swizterland - Meyrin |
Microbial derived immunotherapeutic products |
Diversigen |
TX - Houston |
Microbiome Analysis |
EnteroBiotix |
UK - Aberdeen |
Fecal microbiota transplantation |
Microbiotica |
UK - Cambridge |
Gut Bacteria Phenotype to Biomarker/Therapeutics |
Microbiotica |
UK - Cambridge |
Live Bacterial Therapeutics |
Juno Bio Ltd. |
UK - London |
Vaginal Microbiome Health |
OptiBiotix |
UK - York |
Microbiome Modulator Platform |